A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in England and Wales an option beyond docetaxel.

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment. Dr. Daniel P. Petrylak, a professor of Medicine ...

For Jose Espinoza, peace has always been found in the quiet moments, but in 2022, a persistent pain in his back began to ...

Prostate cancer is something that nobody wants to have. Thankfully, with modern medical advancements, there are different ways to fight and treat the disease. Dr. Gregg Franklin with the New ...